Your browser doesn't support javascript.
loading
Geno- and phenotypic characteristics and clinical outcomes of CACNA1C gene mutation associated Timothy syndrome, "cardiac only" Timothy syndrome and isolated long QT syndrome 8: A systematic review.
Borbás, János; Vámos, Máté; Hategan, Lidia; Hanák, Lilla; Farkas, Nelli; Szakács, Zsolt; Csupor, Dezso; Tél, Bálint; Kupó, Péter; Csányi, Beáta; Nagy, Viktória; Komócsi, András; Habon, Tamás; Hegyi, Péter; Sepp, Róbert.
Afiliación
  • Borbás J; Division of Non-Invasive Cardiology, Department of Internal Medicine, University of Szeged, Member of the European Reference Network for Rare, Low Prevalence, or Complex Diseases of the Heart (ERN GUARD Heart), Szeged, Hungary.
  • Vámos M; Division of Non-Invasive Cardiology, Department of Internal Medicine, University of Szeged, Member of the European Reference Network for Rare, Low Prevalence, or Complex Diseases of the Heart (ERN GUARD Heart), Szeged, Hungary.
  • Hategan L; Division of Non-Invasive Cardiology, Department of Internal Medicine, University of Szeged, Member of the European Reference Network for Rare, Low Prevalence, or Complex Diseases of the Heart (ERN GUARD Heart), Szeged, Hungary.
  • Hanák L; Institute for Translational Medicine, Medical School, University of Pécs, Pécs, Hungary.
  • Farkas N; Institute of Bioanalysis, Medical School, University of Pécs, Pécs, Hungary.
  • Szakács Z; Institute for Translational Medicine, Medical School, University of Pécs, Pécs, Hungary.
  • Csupor D; Division of Cardiology, First Department of Medicine, Medical School, University of Pécs, Pécs, Hungary.
  • Tél B; Institute for Translational Medicine, Medical School, University of Pécs, Pécs, Hungary.
  • Kupó P; Institute of Clinical Pharmacy, University of Szeged, Szeged, Hungary.
  • Csányi B; 1st Department of Pediatrics, Semmelweis University, Budapest, Hungary.
  • Nagy V; Division of Non-Invasive Cardiology, Department of Internal Medicine, University of Szeged, Member of the European Reference Network for Rare, Low Prevalence, or Complex Diseases of the Heart (ERN GUARD Heart), Szeged, Hungary.
  • Komócsi A; Heart Institute, Medical School, University of Pécs, Pécs, Hungary.
  • Habon T; Division of Non-Invasive Cardiology, Department of Internal Medicine, University of Szeged, Member of the European Reference Network for Rare, Low Prevalence, or Complex Diseases of the Heart (ERN GUARD Heart), Szeged, Hungary.
  • Hegyi P; Division of Non-Invasive Cardiology, Department of Internal Medicine, University of Szeged, Member of the European Reference Network for Rare, Low Prevalence, or Complex Diseases of the Heart (ERN GUARD Heart), Szeged, Hungary.
  • Sepp R; Heart Institute, Medical School, University of Pécs, Pécs, Hungary.
Front Cardiovasc Med ; 9: 1021009, 2022.
Article en En | MEDLINE | ID: mdl-36523353
Background: Mutations in the CACNA1C gene-encoding for the major Ca2+ channel of the heart-may exhibit a variety of clinical manifestations. These include typical or atypical Timothy syndromes (TS) which are associated with multiple organ manifestations, and cardiac involvement in form of malignant arrhythmias, QTc prolongation, or AV block. "Cardiac only" Timothy syndrome (COTS) shows no extracardiac manifestation, whereas some CACNA1C gene mutations are associated with QTc prolongation alone (isolated long QT syndrome 8, LQT8). Methods: A systematic search of the literature reporting cases of CACNA1C gene mutation associated syndromes, including TS, COTS and isolated LQT8 via major databases published from 2004 through 2019 was performed. Detailed patient-level phenotypic and genotypic characteristics, as well as long-term outcome measures were collected and compared between pre-specified patient groups, defined both on phenotype and genotype. Results: A total of 59 TS, 6 COTS, and 20 isolated LQT8 index cases were identified. Apart of syndactyly or baldness, there were no major differences regarding clinical manifestations or outcome measures between TS subtypes, either defining TS subtypes on the genotype or based on the phenotype. Both subtypes were characterized by an extreme degree of QTc prolongation (median ≥600 ms) which were reflected in high major adverse cardiac event rate. On the other hand, there were marked differences between TS, COTS, and isolated LQT8. Timothy syndrome was characterized by a much earlier disease onset, much more pronounced QTc prolongation and much higher mortality rate than COTS or isolated LQT8. Similar differences were observed comparing CACNA1C exon 8/8A vs. non-exon 8/8A mutation carriers. TS showed a high degree of genetic homogeneity, as the p.Gly406Arg mutation either in exon 8 or exon 8A alone was responsible for 70% of the cases. Conclusions: Clinical phenotypes associated with mutations in the CACNA1C gene show important clinical differences. Timothy syndrome is associated with the most severe clinical phenotype and with the highest risk of morbidity and mortality. However, distinguishing TS subtypes, in any form, are not supported by our data. Systematic review registration: [https://www.crd.york.ac.uk/prospero/], identifier [CRD42020184737].
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies / Systematic_reviews Idioma: En Revista: Front Cardiovasc Med Año: 2022 Tipo del documento: Article País de afiliación: Hungria Pais de publicación: Suiza

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies / Systematic_reviews Idioma: En Revista: Front Cardiovasc Med Año: 2022 Tipo del documento: Article País de afiliación: Hungria Pais de publicación: Suiza